Galmed Pharmaceuticals (GLMD) Free Cash Flow Growth (3y) (2016 - 2025)
Galmed Pharmaceuticals (GLMD) Free Cash Flow Growth (3y) (2016 - 2025) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
FCF Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
24.91% |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
20.11% |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
14.71% |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Galmed Pharmaceuticals |
2.48 Mn |
-1.63 Mn |
- |
21.57% |
| Date | Value |
|---|
| Dec 31, 2025 |
21.57% |
| Sep 30, 2025 |
14.67% |
| Jun 30, 2025 |
51.49% |
| Mar 31, 2025 |
-66.03% |
| Dec 31, 2024 |
35.20% |
| Sep 30, 2024 |
49.97% |
| Jun 30, 2024 |
48.90% |
| Mar 31, 2024 |
41.80% |
| Dec 31, 2023 |
51.59% |
| Sep 30, 2023 |
26.93% |
| Jun 30, 2023 |
39.76% |
| Mar 31, 2023 |
36.45% |
| Dec 31, 2022 |
0.26% |
| Sep 30, 2022 |
6.93% |
| Jun 30, 2022 |
-51.68% |
| Mar 31, 2022 |
59.42% |
| Dec 31, 2021 |
-46.87% |
| Sep 30, 2021 |
-70.61% |
| Jun 30, 2021 |
-74.01% |
| Mar 31, 2021 |
-38.91% |
